Peripheral Magnetic Stimulation (PMS) Effects on Somatosensory Perception in Patients with Upper Limb Amputation
RecruitingNot applicableNCT06813937
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The study investigates the capabilities of peripheral magnetic stimulation (PMS) as a tool for creating somatosensory sensations of various submodalities and analyzing the dynamics of bioelectric signals of the brain (using encephalography (EEG)) in healthy participants and participants with upper limb amputations. During the experiment, the participants' subjective sensations and EEG activity are recorded in response to magnetic pulses of varying intensity. In addition, the continuous PMS stimulation protocol and its effect on phantom sensations in participants with amputations will be tested for subsequent implementation in clinical practice.
Study details
- Official title
- Peripheral Magnetic Stimulation (PMS) Effects on Somatosensory Perception in Patients with Upper Limb Amputation
- Conditions
- Interventions
- Device: Procedure: Peripheral Magnetic Stimulation (PMS)
- Other: Electroencephalography (EEG)
- Sponsor
- Skolkovo Institute of Science and Technology
- Collaborators
- Motorica LLC
- Start date
- 2024-09-16
- Primary completion
- 2027-09-16
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Russia
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
For Healthy Volunteers: Inclusion Criteria: 1. Availability of signed written informed consent. 2. Absence of somatic and psychiatric diseases (more details in the exclusion criteria) 3. Ability and willingness to comply with the requirements of this protocol. Inclusion Criteria Exclusion Criteria: 1. History of epilepsy (participant, participant's close relatives) 2. Presence of metal or/and electric stimulators and/or implants in participant's body 3. Presence of psychiatric disorders (including a history of), severe depression, suicidal tendencies, or a history of suicide attempts. 4. History of cancer. 5. Complicated traumatic brain injury (TBI) or a history of stroke. 6. Drug addiction (including a history of). 7. Congenital anomaly of upper limb development. 8. Anomalies in the development of the central and peripheral nervous systems. 9. Pregnancy For stroke patients: 1. History of epilepsy (participant, participant's close relatives) 2. Presence of metal or/and electric stimulators and/or implants in participant's body 3. Presence of psychiatric disorders (including a history of), severe depression, suicidal tendencies, or a history of suicide attempts. 4. History of cancer. 5. Complicated traumatic brain injury (TBI) or a history of stroke. 6. Drug addiction (including a history of). 7. Congenital anomaly of upper limb development. 8. Anomalies in the development of the central and peripheral nervous systems. 9. Pregnancy 10. Presence of severe somatic pathology 11. Presence of severe orthopedic deformity in the limb above the level of amputation. 12. Purulent-septic pathology.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06813937